Literature DB >> 25458695

3β-Hydroxysteroid dehydrogenase isoforms in human aldosterone-producing adenoma.

Sachiko Konosu-Fukaya1, Yasuhiro Nakamura1, Fumitoshi Satoh2, Saulo J A Felizola1, Takashi Maekawa1, Yoshikiyo Ono2, Ryo Morimoto2, Kazue Ise1, Ken-Ichiro Takeda3, Koshin Katsu3, Fumiyoshi Fujishima1, Atsuko Kasajima1, Mika Watanabe1, Yoichi Arai4, Elise P Gomez-Sanchez5, Celso E Gomez-Sanchez6, Masao Doi7, Hitoshi Okamura7, Hironobu Sasano8.   

Abstract

It has become important to evaluate the possible involvement of 3β-hydroxysteroid dehydrogenase type 1 (HSD3B1) and 2 (HSD3B2) isoforms in aldosterone-producing adenoma (APA). In this study, we studied 67 and 100 APA cases using real-time quantitative PCR (qPCR) and immunohistochemistry, respectively. Results of qPCR analysis demonstrated that HSD3B2 mRNA was significantly more abundant than HSD3B1 mRNA (P < 0.0001), but only HSD3B1 mRNA significantly correlated with CYP11B2 (aldosterone synthase) mRNA (P <0.0001) and plasma aldosterone concentration (PAC) of the patients (P <0.0001). Results of immunohistochemistry subsequently revealed that HSD3B2 immunoreactivity was detected in the great majority of APA but a significant correlation was also detected between HSD3B1 and CYP11B2 (P <0.0001). In KCNJ5 mutated APA, CYP11B2 mRNA (P <0.0001) and HSD3B1 mRNA (P = 0.011) were significantly higher than those of wild type APA. These results suggest that HSD3B1 is involved in aldosterone production, despite its lower levels of expression compared with HSD3B2, and also possibly associated with KCNJ5 mutation in APA.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  3β-hydroxysteroid dehydrogenase type 1 (HSD3B1); 3β-hydroxysteroid dehydrogenase type 2 (HSD3B2); Aldosterone-producing adenoma (APA); CYP11B1 (11β-hydroxylase) and KCNJ5; CYP11B2 (aldosterone synthase)

Mesh:

Substances:

Year:  2014        PMID: 25458695      PMCID: PMC4821076          DOI: 10.1016/j.mce.2014.10.008

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  35 in total

1.  Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism.

Authors:  Sheerazed Boulkroun; Felix Beuschlein; Gian-Paolo Rossi; José-Felipe Golib-Dzib; Evelyn Fischer; Laurence Amar; Paolo Mulatero; Benoit Samson-Couterie; Stefanie Hahner; Marcus Quinkler; Francesco Fallo; Claudio Letizia; Bruno Allolio; Giulio Ceolotto; Maria Verena Cicala; Katharina Lang; Hervé Lefebvre; Livia Lenzini; Carmela Maniero; Silvia Monticone; Maelle Perrocheau; Catia Pilon; Pierre-François Plouin; Nada Rayes; Teresa M Seccia; Franco Veglio; Tracy Ann Williams; Laura Zinnamosca; Franco Mantero; Arndt Benecke; Xavier Jeunemaitre; Martin Reincke; Maria-Christina Zennaro
Journal:  Hypertension       Date:  2012-01-23       Impact factor: 10.190

2.  Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis.

Authors:  Kenji Oki; Maria W Plonczynski; Milay Luis Lam; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Endocrinology       Date:  2012-02-07       Impact factor: 4.736

3.  Medicine. The genetics of primary aldosteronism.

Authors:  John W Funder
Journal:  Science       Date:  2011-02-11       Impact factor: 47.728

4.  Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors.

Authors:  Elena A B Azizan; Brian Y H Lam; Stephen J Newhouse; Junhua Zhou; Rhoda E Kuc; Jennifer Clarke; Lisa Happerfield; Alison Marker; Gary J Hoffman; Morris J Brown
Journal:  J Clin Endocrinol Metab       Date:  2012-03-22       Impact factor: 5.958

Review 5.  Selective inhibition of human 3β-hydroxysteroid dehydrogenase type 1 as a potential treatment for breast cancer.

Authors:  James L Thomas; Kevin M Bucholtz; Balint Kacsoh
Journal:  J Steroid Biochem Mol Biol       Date:  2010-08-22       Impact factor: 4.292

6.  Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6.

Authors:  Masao Doi; Yukari Takahashi; Rie Komatsu; Fumiyoshi Yamazaki; Hiroyuki Yamada; Shogo Haraguchi; Noriaki Emoto; Yasushi Okuno; Gozoh Tsujimoto; Akihiro Kanematsu; Osamu Ogawa; Takeshi Todo; Kazuyoshi Tsutsui; Gijsbertus T J van der Horst; Hitoshi Okamura
Journal:  Nat Med       Date:  2009-12-13       Impact factor: 53.440

7.  Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis.

Authors:  Tracy Ann Williams; Silvia Monticone; Valentina Crudo; Richard Warth; Franco Veglio; Paolo Mulatero
Journal:  Hypertension       Date:  2012-02-13       Impact factor: 10.190

8.  A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.

Authors:  Gian Paolo Rossi; Giampaolo Bernini; Chiara Caliumi; Giovambattista Desideri; Bruno Fabris; Claudio Ferri; Chiara Ganzaroli; Gilberta Giacchetti; Claudio Letizia; Mauro Maccario; Francesca Mallamaci; Massimo Mannelli; Mee-Jung Mattarello; Angelica Moretti; Gaetana Palumbo; Gabriele Parenti; Enzo Porteri; Andrea Semplicini; Damiano Rizzoni; Ermanno Rossi; Marco Boscaro; Achille Cesare Pessina; Franco Mantero
Journal:  J Am Coll Cardiol       Date:  2006-11-13       Impact factor: 24.094

9.  K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.

Authors:  Murim Choi; Ute I Scholl; Peng Yue; Peyman Björklund; Bixiao Zhao; Carol Nelson-Williams; Weizhen Ji; Yoonsang Cho; Aniruddh Patel; Clara J Men; Elias Lolis; Max V Wisgerhof; David S Geller; Shrikant Mane; Per Hellman; Gunnar Westin; Göran Åkerström; Wenhui Wang; Tobias Carling; Richard P Lifton
Journal:  Science       Date:  2011-02-11       Impact factor: 47.728

10.  Role of angiotensin II-induced rapid response genes in the regulation of enzymes needed for aldosterone synthesis.

Authors:  Edson F Nogueira; Yewei Xing; Claudia A V Morris; William E Rainey
Journal:  J Mol Endocrinol       Date:  2009-01-21       Impact factor: 5.098

View more
  16 in total

1.  Histopathological Classification of Cross-Sectional Image-Negative Hyperaldosteronism.

Authors:  Yuto Yamazaki; Yasuhiro Nakamura; Kei Omata; Kazue Ise; Yuta Tezuka; Yoshikiyo Ono; Ryo Morimoto; Yukinaga Nozawa; Celso E Gomez-Sanchez; Scott A Tomlins; William E Rainey; Sadayoshi Ito; Fumitoshi Satoh; Hironobu Sasano
Journal:  J Clin Endocrinol Metab       Date:  2017-04-01       Impact factor: 5.958

Review 2.  Review of Markers of Zona Glomerulosa and Aldosterone-Producing Adenoma Cells.

Authors:  Teresa M Seccia; Brasilina Caroccia; Elise P Gomez-Sanchez; Paul-Emmanuel Vanderriele; Celso E Gomez-Sanchez; Gian Paolo Rossi
Journal:  Hypertension       Date:  2017-09-25       Impact factor: 10.190

3.  Pre-B Lymphocyte Protein 3 (VPREB3) Expression in the Adrenal Cortex: Precedent for non-Immunological Roles in Normal and Neoplastic Human Tissues.

Authors:  Saulo J A Felizola; Koshin Katsu; Kazue Ise; Yasuhiro Nakamura; Yoichi Arai; Fumitoshi Satoh; Hironobu Sasano
Journal:  Endocr Pathol       Date:  2015-05       Impact factor: 3.943

4.  Development of monoclonal antibodies against the human 3β-hydroxysteroid dehydrogenase/isomerase isozymes.

Authors:  Celso E Gomez-Sanchez; Mark Lewis; Kazutaka Nanba; William E Rainey; Maniselvan Kuppusamy; Elise P Gomez-Sanchez
Journal:  Steroids       Date:  2017-08-31       Impact factor: 2.668

Review 5.  Immunohistochemical Biomarkers of Adrenal Cortical Neoplasms.

Authors:  Ozgur Mete; Sylvia L Asa; Thomas J Giordano; Mauro Papotti; Hironobu Sasano; Marco Volante
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

6.  Tumor Cell Subtypes Based on the Intracellular Hormonal Activity in KCNJ5-Mutated Aldosterone-Producing Adenoma.

Authors:  Yuto Yamazaki; Kei Omata; Yuta Tezuka; Yoshikiyo Ono; Ryo Morimoto; Yuzu Adachi; Kazue Ise; Yasuhiro Nakamura; Celso E Gomez-Sanchez; Yukiko Shibahara; Takumi Kitamoto; Tetsuo Nishikawa; Sadayoshi Ito; Fumitoshi Satoh; Hironobu Sasano
Journal:  Hypertension       Date:  2018-09       Impact factor: 10.190

7.  Intratumoral heterogeneity of steroidogenesis in aldosterone-producing adenoma revealed by intensive double- and triple-immunostaining for CYP11B2/B1 and CYP17.

Authors:  Yasuhiro Nakamura; Masaaki Kitada; Fumitoshi Satoh; Takashi Maekawa; Ryo Morimoto; Yuto Yamazaki; Kazue Ise; Celso E Gomez-Sanchez; Sadayoshi Ito; Yoichi Arai; Mari Dezawa; Hironobu Sasano
Journal:  Mol Cell Endocrinol       Date:  2015-11-17       Impact factor: 4.102

Review 8.  Immunohistochemistry of the adrenal in primary aldosteronism.

Authors:  Celso E Gomez-Sanchez; Elise P Gomez-Sanchez
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-06       Impact factor: 3.243

9.  The role of mineralocorticoids and glucocorticoids under the impact of 11β-hydroxysteroid dehydrogenase in human breast lesions.

Authors:  Mingzhen Cai; Keely McNamara; Yuto Yamazaki; Narumi Harada; Minoru Miyashita; Hiroshi Tada; Takanori Ishida; Hironobu Sasano
Journal:  Med Mol Morphol       Date:  2022-02-01       Impact factor: 2.309

Review 10.  Molecular and Cellular Mechanisms of Aldosterone Producing Adenoma Development.

Authors:  Sheerazed Boulkroun; Fabio Luiz Fernandes-Rosa; Maria-Christina Zennaro
Journal:  Front Endocrinol (Lausanne)       Date:  2015-06-11       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.